[1] |
Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management[J]. J Eur Acad Dermatol Venereol, 2012,26(Suppl 2):3⁃11. doi: 10.1111/j.1468⁃3083. 2011.04410.x.
|
[2] |
Babalola O, Strober BE. Management of psoriasis in pregnancy[J]. Dermatol Ther, 2013,26(4):285⁃292. doi: 10.1111/dth.12073.
|
[3] |
Ogdie A, Haynes K, Troxel AB, et al. Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study[J]. Ann Rheum Dis, 2014,73(1):149⁃153. doi: 10.1136/annrheumdis⁃2012⁃202424.
|
[4] |
Confavreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy⁃related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group[J]. N Engl J Med, 1998,339(5):285⁃291. doi: 10.1056/NEJM199807303390501.
|
[5] |
Ben⁃David G, Sheiner E, Hallak M, et al. Pregnancy outcome in women with psoriasis[J]. J Reprod Med, 2008,53(3):183⁃187.
|
[6] |
Seeger JD, Lanza LL, West WA, et al. Pregnancy and pregnancy outcome among women with inflammatory skin diseases[J]. Dermatology, 2007,214(1):32⁃39. doi: 10.1159/000096910.
|
[7] |
Lima XT, Janakiraman V, Hughes MD, et al. The impact of psoriasis on pregnancy outcomes[J]. J Invest Dermatol, 2012,132(1):85⁃91. doi: 10.1038/jid.2011.271.
|
[8] |
Stroup DF, Berlin JA, Morton SC, et al. Meta⁃analysis of observational studies in epidemiology: a proposal for reporting. Meta⁃analysis Of Observational Studies in Epidemiology (MOOSE) group[J]. JAMA, 2000,283(15):2008⁃2012. doi: 10. 1001/jama.283.15.2008.
|
[9] |
Bröms G, Haerskjold A, Granath F, et al. Effect of maternal psoriasis on pregnancy and birth outcomes: a population⁃based cohort study from Denmark and Sweden[J]. Acta Derm Venereol, 2018,98(8):728⁃734. doi: 10.2340/00015555⁃2923.
|
[10] |
Cohen⁃Barak E, Nachum Z, Rozenman D, et al. Pregnancy outcomes in women with moderate⁃to⁃severe psoriasis[J]. J Eur Acad Dermatol Venereol, 2011,25(9):1041⁃1047. doi: 10.1111/j.1468⁃3083.2010.03917.x.
|
[11] |
Yang YW, Chen CS, Chen YH, et al. Psoriasis and pregnancy outcomes: a nationwide population⁃based study[J]. J Am Acad Dermatol, 2011,64(1):71⁃77. doi: 10.1016/j.jaad.2010.02.005.
|
[12] |
Harder E, Andersen AN, Kamper⁃Jørgensen M, et al. No increased risk of fetal death or prolonged time to pregnancy in women with psoriasis[J]. J Invest Dermatol, 2014,134(6):1747⁃1749. doi: 10.1038/jid.2014.35.
|
[13] |
Christophers E. Psoriasis⁃⁃epidemiology and clinical spectrum[J]. Clin Exp Dermatol, 2001,26(4):314⁃320. doi: 10.1046/j. 1365⁃2230.2001.00832.x.
|
[14] |
Solmaz D, Eder L, Aydin SZ. Update on the epidemiology, risk factors, and disease outcomes of psoriatic arthritis[J]. Best Pract Res Clin Rheumatol, 2018,32(2):295⁃311. doi: 10.1016/j.berh.2018.09.006.
|
[15] |
Mouyis MA, Thornton CC, Williams D, et al. Pregnancy outcomes in patients with psoriatic arthritis[J]. J Rheumatol, 2017,44(1):128⁃129. doi: 10.3899/jrheum.160929.
|
[16] |
Confavreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy⁃related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group[J]. N Engl J Med, 1998,339(5):285⁃291. doi: 10.1056/NEJM199807303390501.
|
[17] |
Boyd AS, King LE Jr. Tamoxifen⁃induced remission of psoriasis[J]. J Am Acad Dermatol, 1999,41(5 Pt 2):887⁃889. doi: 10. 1016/s0190⁃9622(99)70356⁃7.
|
[18] |
余灿清, 詹思延. 如何撰写高质量的流行病学研究论文第二讲遗传关联性研究及其Meta分析的报告规范[J]. 中华流行病学杂志, 2006,27(8):728⁃730. doi: 10.3760/j.issn:0254⁃6450. 2006.08.022.
|